824 related articles for article (PubMed ID: 106067)
1. Normal adults and subjects with hypogonadotropic hypogonadism respond differently to D-Ser(TBU)6-LH-RH-EA10.
Smith R; Donald RA; Espiner EA; Stronach SG; Edwards IA
J Clin Endocrinol Metab; 1979 Jan; 48(1):167-70. PubMed ID: 106067
[TBL] [Abstract][Full Text] [Related]
2. Effect of a new LH-RH analogue (D-Ser(TBU)6-EA10-LH-RH) on gonadotrophin and gonadal steroid secretion in men.
Wiegelmann W; Solbach HG; Kley HK; Nieschlag E; Rudorff KH; Krüskemper HL
Horm Res; 1976; 7(1):1-10. PubMed ID: 793974
[TBL] [Abstract][Full Text] [Related]
3. The effects of prolonged administration of D-Ser (TBU)6-LH-RH-EA10 (HOE 766) in subjects with hypogonadotrophic hypogonadism.
Smith R; Donald RA; Espiner EA; Stronach S
Clin Endocrinol (Oxf); 1979 Nov; 11(5):553-9. PubMed ID: 391447
[No Abstract] [Full Text] [Related]
4. Treatment of hypogonadotropic hypogonadal male patients with the luteinizing hormone-relasing hormone (LH-RH) anolog D-Ser(TBU)6 EA10 LH-RH: transient disappearance of gonadotropin stimulation.
Morel Y; Fournier M; Mazenod B; Tourniaire J; Mornex R
Fertil Steril; 1982 Jul; 38(1):85-91. PubMed ID: 6807722
[TBL] [Abstract][Full Text] [Related]
5. The effects of different dose regimes of D-SER(TBU)6-LHRH-EA10 (HOE 766) in subjects with hypogonadotrophic hypogonadism.
Moore MP; Smith R; Donald RA; Espiner EA; Stronach S
Clin Endocrinol (Oxf); 1981 Jan; 14(1):93-7. PubMed ID: 6784983
[TBL] [Abstract][Full Text] [Related]
6. Pulsatile gonadotropin secretion after discontinuation of long term gonadotropin-releasing hormone (GnRH) administration in a subset of GnRH-deficient men.
Finkelstein JS; Spratt DI; O'Dea LS; Whitcomb RW; Klibanski A; Schoenfeld DA; Crowley WF
J Clin Endocrinol Metab; 1989 Aug; 69(2):377-85. PubMed ID: 2502554
[TBL] [Abstract][Full Text] [Related]
7. Effects of decreasing the frequency of gonadotropin-releasing hormone stimulation on gonadotropin secretion in gonadotropin-releasing hormone-deficient men and perifused rat pituitary cells.
Finkelstein JS; Badger TM; O'Dea LS; Spratt DI; Crowley WF
J Clin Invest; 1988 Jun; 81(6):1725-33. PubMed ID: 3290251
[TBL] [Abstract][Full Text] [Related]
8. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
Wang C; Tso SC; Todd D
J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of male hypogonadotropic hypogonadism and constitutional delay of puberty by pulsatile administration of gonadotropin-releasing hormone.
Partsch CJ; Hermanussen M; Sippell WG
J Clin Endocrinol Metab; 1985 Jun; 60(6):1196-203. PubMed ID: 3923024
[TBL] [Abstract][Full Text] [Related]
10. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
Mortimer RH; Fleischer N; Lev-Gur M; Freeman RG
J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
[TBL] [Abstract][Full Text] [Related]
11. Effect of thyrotropin-releasing hormone and gonadotropin-releasing hormone on serum TSH, PRL, hGH, FSH and LH in primary testicular failure and in hypogonadotrophic hypogonadism.
Szilágyi G; Szabolcs I; Vydra G; Góth M; Irsy G
Acta Med Hung; 1984; 41(4):175-83. PubMed ID: 6440114
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
13. Biphasic change in pituitary capacity induced by estrogen in hypogonadal women.
Lachelin GC; Yen SS
J Clin Endocrinol Metab; 1978 Mar; 46(3):369-73. PubMed ID: 109457
[TBL] [Abstract][Full Text] [Related]
14. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
Lasley BL; Wang CF; Yen SS
J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
Nillius SJ; Bergquist C; Wide L
Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic hypogonadotropic hypogonadism in men: dependence of the hormone responses to gonadotropin-releasing hormone (GnRH) on the magnitude of the endogenous GnRH secretory defect.
Barkan AL; Reame NE; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1985 Dec; 61(6):1118-25. PubMed ID: 3932448
[TBL] [Abstract][Full Text] [Related]
17. The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men.
Crowley WF; Beitins IZ; Vale W; Kliman B; Rivier J; Rivier C; McArthur JW
N Engl J Med; 1980 May; 302(19):1052-7. PubMed ID: 6767977
[TBL] [Abstract][Full Text] [Related]
18. Ovulation inhibition by daily i.m. administration of a highly active LH-RH analog (d-ser(TBU)6-LH-RH-(1-9)-nonapeptide-ethylamide).
Baumann R; Kuhl H; Taubert HD; Sandow J
Contraception; 1980 Feb; 21(2):191-7. PubMed ID: 6768492
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone (GnRH) physiology in men and women.
Santoro N; Filicori M; Spratt D; Crowley WF
Acta Med Hung; 1986; 43(2):201-21. PubMed ID: 3295743
[TBL] [Abstract][Full Text] [Related]
20. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
